To revascularize or not before transcatheter aortic valve implantation?

Sergio Perez1, Torin P Thielhelm2, Mauricio G Cohen1

  • 1Cardiovascular Division, University of Miami Miller School of Medicine, Miami, FL, USA.

Insights

Management of coronary artery disease (CAD) in patients undergoing transcatheter aortic valve replacement (TAVR) is complex. While guidelines exist for surgical repair, TAVR introduces new considerations for revascularization strategies to optimize patient outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Concomitant coronary artery disease (CAD) and aortic stenosis affect 60-75% of patients undergoing aortic valve replacement.
  • Current guidelines recommend simultaneous surgical aortic valve replacement and bypass surgery for CAD, based on limited evidence.
  • Transcatheter aortic valve replacement (TAVR) has challenged traditional revascularization strategies, with observational studies showing no significant outcome differences in TAVR patients with or without CAD.

Purpose of the Study:

  • To review the management of coronary artery disease (CAD) in patients undergoing transcatheter aortic valve replacement (TAVR).
  • To discuss the indications, timing, and technical considerations for percutaneous coronary intervention (PCI) in TAVR candidates.
  • To explore adjunctive pharmacological therapies and future research directions.

Main Methods:

  • Review of current guidelines and observational studies.
  • Analysis of percutaneous coronary intervention (PCI) strategies before, during, and after TAVR.
  • Discussion of technical aspects, device selection, and pharmacological therapies.

Main Results:

  • Percutaneous coronary intervention (PCI) in aortic stenosis patients is safe, but optimal timing and indications remain debated.
  • Complete revascularization before TAVR may benefit selected patients with extensive CAD.
  • Combined PCI and TAVR or PCI after TAVR are options for specific clinical scenarios.

Conclusions:

  • The optimal management of CAD in TAVR candidates requires careful consideration of individual patient factors and lesion characteristics.
  • Randomized clinical trials are needed to further clarify the role and indications of revascularization in the TAVR population.
  • This review provides comprehensive insights into managing CAD in TAVR candidates, including technical and pharmacological aspects.

Related Concept Videos

Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
12.1K
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
521
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
609
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
574
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
374
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
443